Ireland - English - HPRA (Health Products Regulatory Authority)

organon pharma (ireland) limited - finasteride - film-coated tablet - 5 milligram(s) - testosterone-5-alpha reductase inhibitors; finasteride

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - tadalafil, quantity: 20 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; pregelatinised maize starch; magnesium stearate; croscarmellose sodium; sodium lauryl sulfate; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow - tadalafil gh (tadalafil 20 mg tablets) are indicated for the treatment of: ? erectile dysfunction (ed) in adult males.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - tadalafil, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; croscarmellose sodium; sodium lauryl sulfate; magnesium stearate; microcrystalline cellulose; pregelatinised maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow - tadalafil gh (tadalafil 5 mg tablets) are indicated for the treatment of: ? erectile dysfunction (ed) in adult males; and ? moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - tadalafil, quantity: 10 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; magnesium stearate; sodium lauryl sulfate; croscarmellose sodium; pregelatinised maize starch; titanium dioxide; hypromellose; purified talc; triacetin; iron oxide yellow - tadalafil gh (tadalafil 10 mg tablets) are indicated for the treatment of: ? erectile dysfunction (ed) in adult males.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - finasteride, quantity: 1 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; sodium starch glycollate type a; magnesium stearate; lauroyl macrogolglycerides; microcrystalline cellulose; lactose monohydrate; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red - finasteride mylan is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. efficacy has not been demonstrated in men over the age of 41 years. finasteride mylan is not indicated for use in women (see use in pregnancy and clinical studies) or children.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tadalafil, quantity: 5 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; povidone; microcrystalline cellulose; sodium lauryl sulfate; poloxamer; colloidal anhydrous silica; lactose; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow - tadalafil alphapharm is indicated for the treatment of:,? erectile dysfunction (ed) in adult males,? moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - tadalafil, quantity: 5 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; poloxamer; sodium lauryl sulfate; magnesium stearate; lactose; microcrystalline cellulose; croscarmellose sodium; povidone; titanium dioxide; lactose monohydrate; hypromellose; triacetin; iron oxide yellow - cilatil is indicated for the treatment of:,? erectile dysfunction (ed) in adult males,? moderate to severe lower urinary tract symptoms (luts) associated with benign prostatic hyperplasia (bph) in adult males

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - finasteride, quantity: 1 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; sodium starch glycollate type a; silicon dioxide; docusate sodium; sodium benzoate; titanium dioxide; hypromellose; macrogol 6000; iron oxide red - cipla finasteride 1 is indicated for the treatment of male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss in men 18 years or older. efficacy has not been demonstrated in men over the age of 41 years.,cipla finasteride 1 is not indicated for use in women (see use in pregnancy and clinical studies) or children.

Malta - English - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - finasteride - film-coated tablet - finasteride 5 mg - urologicals

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - finasteride - film-coated tablet - finasteride 5 mg - urologicals